Chromium-51 is used as a diagnostic radiopharmaceutical agent in nephrology to determine glomerular filtration rate, and in hematology to determine red blood cell volume or mass, study the red blood cell survival time and evaluate blood loss.

The global Chromium-51 market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime 's newest research report, the “Chromium-51 Industry Forecast” looks at past sales and reviews total world Chromium-51 sales in 2023, providing a comprehensive analysis by region and market sector of projected Chromium-51 sales for 2024 through 2030.

This Insight Report provides a comprehensive analysis of the global Chromium-51 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also analyzes the strategies of leading global companies with a focus on Chromium-51 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chromium-51 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chromium-51 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

United States market for Chromium-51 is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Chromium-51 is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Chromium-51 is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Chromium-51 players cover:

• Rosatom
• NIDC(DOE IP)
• ANSTO
• Trace Sciences International
• Buyisotope(Neonest AB)

In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Chromium-51 market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Activity Concentration<10mCi/mL
• Activity Concentration≥10mCi/mL

Segmentation by Application:

• Radiopharmaceutical Agent
• Scientific Research

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Rosatom
• NIDC(DOE IP)
• ANSTO
• Trace Sciences International
• Buyisotope(Neonest AB)

Key Questions Addressed in this Report:

1. What is the 10-year outlook for the global Chromium-51 market?
2. What factors are driving Chromium-51 market growth, globally and by region?
3. Which technologies are poised for the fastest growth by market and region?
4. How do Chromium-51 market opportunities vary by end market size?
5. How does Chromium-51 break out by Type, by Application?